365 related articles for article (PubMed ID: 20855046)
1. Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.
Gamo NJ; Wang M; Arnsten AF
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1011-23. PubMed ID: 20855046
[TBL] [Abstract][Full Text] [Related]
2. Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors.
Di Miceli M; Gronier B
Psychopharmacology (Berl); 2015 Jun; 232(12):2191-205. PubMed ID: 25572531
[TBL] [Abstract][Full Text] [Related]
3. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptors.
Gronier B
Eur Neuropsychopharmacol; 2011 Feb; 21(2):192-204. PubMed ID: 21146374
[TBL] [Abstract][Full Text] [Related]
4. Catecholamine influences on dorsolateral prefrontal cortical networks.
Arnsten AF
Biol Psychiatry; 2011 Jun; 69(12):e89-99. PubMed ID: 21489408
[TBL] [Abstract][Full Text] [Related]
5. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.
Ni HC; Shang CY; Gau SS; Lin YJ; Huang HC; Yang LK
Int J Neuropsychopharmacol; 2013 Oct; 16(9):1959-73. PubMed ID: 23672818
[TBL] [Abstract][Full Text] [Related]
6. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
Husarova V; Bittsansky M; Ondrejka I; Dobrota D
Psychiatry Res; 2014 Apr; 222(1-2):75-83. PubMed ID: 24679996
[TBL] [Abstract][Full Text] [Related]
7. Receptor and circuit mechanisms underlying differential procognitive actions of psychostimulants.
Spencer RC; Berridge CW
Neuropsychopharmacology; 2019 Sep; 44(10):1820-1827. PubMed ID: 30683912
[TBL] [Abstract][Full Text] [Related]
8. Dopamine vs noradrenaline: inverted-U effects and ADHD theories.
Levy F
Aust N Z J Psychiatry; 2009 Feb; 43(2):101-8. PubMed ID: 19153917
[TBL] [Abstract][Full Text] [Related]
9. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness.
Devilbiss DM; Berridge CW
Biol Psychiatry; 2008 Oct; 64(7):626-35. PubMed ID: 18585681
[TBL] [Abstract][Full Text] [Related]
10. Differential Treatment Effects of Methylphenidate and Atomoxetine on Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder.
Wu CS; Shang CY; Lin HY; Gau SS
J Child Adolesc Psychopharmacol; 2021 Apr; 31(3):187-196. PubMed ID: 33890819
[No Abstract] [Full Text] [Related]
11. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
Kodama T; Kojima T; Honda Y; Hosokawa T; Tsutsui KI; Watanabe M
J Neurosci; 2017 Mar; 37(9):2387-2394. PubMed ID: 28154152
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder.
Arnsten AF; Dudley AG
Behav Brain Funct; 2005 Apr; 1(1):2. PubMed ID: 15916700
[TBL] [Abstract][Full Text] [Related]
13. Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.
Roskell NS; Setyawan J; Zimovetz EA; Hodgkins P
Curr Med Res Opin; 2014 Aug; 30(8):1673-85. PubMed ID: 24627974
[TBL] [Abstract][Full Text] [Related]
14. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
[TBL] [Abstract][Full Text] [Related]
15. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.
Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer MJ; Simmons A; Rubia K
Cereb Cortex; 2014 Jan; 24(1):174-85. PubMed ID: 23048018
[TBL] [Abstract][Full Text] [Related]
16. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
17. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task.
Sawaguchi T; Goldman-Rakic PS
J Neurophysiol; 1994 Feb; 71(2):515-28. PubMed ID: 7909839
[TBL] [Abstract][Full Text] [Related]
18. Methylphenidate affects task-switching and neural signaling in non-human primates.
Rajala AZ; Populin LC; Jenison RL
Psychopharmacology (Berl); 2020 May; 237(5):1533-1543. PubMed ID: 32067136
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors.
Cheng J; Xiong Z; Duffney LJ; Wei J; Liu A; Liu S; Chen GJ; Yan Z
Biol Psychiatry; 2014 Dec; 76(12):953-62. PubMed ID: 24832867
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of atomoxetine and methylphenidate for problematic online gaming in adolescents with attention deficit hyperactivity disorder.
Park JH; Lee YS; Sohn JH; Han DH
Hum Psychopharmacol; 2016 Nov; 31(6):427-432. PubMed ID: 27859666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]